Biotech Funding, Policy, and Cancer Advances
Kilder
- STAT: Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success
- STAT: After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward - STAT
- STAT: STAT+: On Wall Street, there’s trouble stirring for biotech
- STAT: Mass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China - STAT
- Endpoints: OMass Therapeutics collects $310M to chase Neurocrine, Vertex in genetic adrenal disorder
- Endpoints: Updated: Iambic rises after $150M IPO for AI-driven cancer pipeline
- BioPharma Dive: Iambic, an AI drug discovery specialist, banks $150M in an IPO - BioPharma Dive
- Medcitynews: AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D - MedCity News
- Endpoints: Paul Stoffels to bring Galapagos’ cell therapies back to life
- BioSpace: Stoffels strikes up new biotech in return to Galapagos cell therapy mission - BioSpace
- Fierce Biotech: Rebranded Galapagos finally finds buyer for unwanted cell therapy pipeline - Fierce Biotech
- STAT: Mass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China
- STAT: The Trump administration is doubling down on health care fraud investigations - STAT
- STAT: Trump administration advances plan for peptide drugs favored by RFK Jr. - STAT
- wikimedia: Photo by Authors of the study: Harry Klein, Tali Mazor, Ethan Siegel, Pavel Trukhanov, Andrea Ovalle, Catherine Del Vecchio Fitz, Zachary Zwiesler, Priti Kumari, Bernd Van Der Veen, Eric Marriott, Jason Hansel, Joyce Yu, Adem Albayrak, Susan Barry, Rachel B. Keller, Laura E. MacConaill, Neal Lindeman, Bruce E. Johnson, Barrett J. Rollins, Khanh T. Do, Brian Beardslee, Geoffrey Shapiro, Suzanne Hector-Barry, John Methot, Lynette Sholl, James Lindsay, Michael J. Hassett & Ethan Cerami / Wikimedia Commons / CC BY 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.